Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not

Otto Hemminki, Akseli Hemminki, Johan Björklund et al.|European Urology Open Science|2020

Cited by 15